Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
Anaplastic large cell lymphoma (ALCL) is the most common T-cell lymphoma in children. ALCL cells characteristically express surface CD30 molecules and carry the pathogenic ALK oncogene, both of which are diagnostic biomarkers and are also potential therapeutic targets. For precision therapy, we repo...
Main Authors: | Zihua Zeng, Ching-Hsuan Tung, Youli Zu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/4/780 |
Similar Items
-
A Cancer Cell-Activatable Aptamer-Reporter System for One-Step Assay of Circulating Tumor Cells
by: Zihua Zeng, et al.
Published: (2014-01-01) -
Comparison of Protamine 1 to Protamine 2 mRNA Ratio and YBX2 gene mRNA Content in Testicular Tissue of Fertile and Azoospermic Men
by: Sahar Moghbelinejad, et al.
Published: (2015-10-01) -
Targeted-Lymphoma Drug Delivery System Based on the Sgc8-c Aptamer
by: Estefanía Sicco, et al.
Published: (2023-02-01) -
Chromomycin A3 Staining Indicates Sperm Protamine Deficiency
by: Mohammad Hossein Nasr-Esfahani, et al.
Published: (2007-03-01) -
The Role of Sperm Protamine in Pathogenesis of Male Infertility
by: marzieh tavalaee, et al.
Published: (2019-07-01)